Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – A survival model with external validation-Reference-Cited by-同舟云学术

Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – A survival model with external validation

Published:2016-06 Issue:3 Volume:119 Page:487-494
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Carvalho Sara,Troost Esther G.C.,Bons Judith,Menheere Paul,Lambin Philippe,Oberije Cary

Funder

IMIJU

Dutch technology Foundation

CTMM

Dutch Cancer Society

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference58 articles.

1. Global cancer incidence and mortality rates and trends-an update;Torre;Cancer Epidemiol Biomarkers Prev,2016

2. A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer;Dingemans;J Thorac Oncol,2014

3. Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study;De Ruysscher;Radiother Oncol,2012

4. Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450);De Ruysscher;J Thorac Oncol,2012

5. Lambin P, Roelofs E Fau – Reymen B, Reymen B Fau – Velazquez ER, Velazquez Er Fau – Buijsen J, Buijsen J Fau – Zegers CML, Zegers Cm Fau – Carvalho S, et al. Rapid Learning health care in oncology – an approach towards decision support systems enabling customised radiotherapy’. Radiother Oncol. 109(1):159–64.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient;Acta Pharmacologica Sinica;2024-02-15

2. Hypoxia A Typical Target in Human Lung Cancer Therapy;Current Protein & Peptide Science;2023-11-29

3. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update;Tumor Biology;2023-10-28

4. Artificial intelligence to predict outcomes of head and neck radiotherapy;Clinical and Translational Radiation Oncology;2023-03

5. Janus nanozyme based satellite structure immunosandwich colorimetric strategy for glycoproteins visual detection;Chemical Engineering Journal;2023-02